glp-1 for metabolic syndrome Resmetirom and agonists MASH: complementary rather than exclusive The Role of Glp-1 Receptor

Processed food

For Michael Miedema, MD (Minneapolis Heart Institute Foundation, MN), the up-front conversation with patients starting weight-loss medications is critical, particularly since this is not about cosmetic weight loss but improvements to cardiovascular health

ARPE-19 cell growth and cell functions in euglycemic culture media

Ghosh S, Ting S, Lau H, Pulinilkunnil T, An D, Qi D, et al

Reconstituting cold vials can cause incomplete dissolution and peptide aggregation

Both are on the July 2026 Pharmacy Compounding Advisory Committee agenda for 503A compounding review, which is a separate regulatory question from approval